Literature DB >> 29436268

Patient Decision Making in Vestibular Schwannoma: A Survey of the Acoustic Neuroma Association.

Omid Moshtaghi1, Khodayar Goshtasbi1, Ronald Sahyouni1,2, Harrison W Lin1,2, Hamid R Djalilian1,2.   

Abstract

Objective To assess the decision-making process of patients with vestibular schwannoma (VS). Study Design Patients with VS completed a voluntary survey over a 3-month period. Setting Surveys were distributed online through email, Facebook, and member website. Subjects and Methods All patients had a diagnosis of VS and were members of the Acoustic Neuroma Association (ANA). A total of 789 patients completed the online survey. Results Of the 789 participants, 474 (60%) cited physician recommendation as a significant influential factor in deciding treatment. In our sample, 629 (80%) saw multiple VS specialists and 410 (52%) sought second opinions within the same specialty. Of those who received multiple consults, 242 (59%) of patients reported receiving different opinions regarding treatment. Those undergoing observation spent significantly less time with the physician (41 minutes) compared to surgery (68 minutes) and radiation (60 minutes) patients ( P < .001). A total of 32 (4%) patients stated the physician alone made the decision for treatment, and 29 (4%) felt they did not understand all possible treatment options before final decision was made. Of the 414 patients who underwent surgery, 66 (16%) felt they were pressured by the surgeon to choose surgical treatment. Conclusion Deciding on a proper VS treatment for patients can be complicated and dependent on numerous clinical and individual factors. It is clear that many patients find it important to seek second opinions from other specialties. Moreover, second opinions within the same specialty are common, and the number of neurotologists consulted correlated with higher decision satisfaction.

Entities:  

Keywords:  acoustic neuroma; decision making; patient satisfaction; shared decision making; vestibular schwannoma

Mesh:

Year:  2018        PMID: 29436268     DOI: 10.1177/0194599818756852

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  7 in total

1.  Are Acoustic Neuroma Association Patients Characteristically Different Than the General Population Patients? The Benefits and Drawbacks of Survey-Based Studies.

Authors:  Khodayar Goshtasbi; Mehdi Abouzari; Hamid R Djalilian
Journal:  Otol Neurotol       Date:  2019-08       Impact factor: 2.311

2.  The Patient-Centered Approach: A Review of the Literature and Its Application for Acoustic Neuromas.

Authors:  Christopher S Hong; Jennifer Moliterno
Journal:  J Neurol Surg B Skull Base       Date:  2019-06-06

3.  Main Symptom that Led to Medical Evaluation and Diagnosis of Vestibular Schwannoma and Patient-Reported Tumor Size: Cross-sectional Study in 1,304 Patients.

Authors:  Maria Peris-Celda; Christopher S Graffeo; Avital Perry; Panagiotis Kerezoudis; Nicole M Tombers; Matthew L Carlson; Michael J Link
Journal:  J Neurol Surg B Skull Base       Date:  2018-10-09

4.  The changing landscape of vestibular schwannoma diagnosis and management: A cross-sectional study.

Authors:  Khodayar Goshtasbi; Mehdi Abouzari; Omid Moshtaghi; Ronald Sahyouni; Autefeh Sajjadi; Harrison W Lin; Hamid R Djalilian
Journal:  Laryngoscope       Date:  2019-04-05       Impact factor: 3.325

5.  Treatment Analysis and Overall Survival Outcomes of Patients With Bilateral Vestibular Schwannoma.

Authors:  Khodayar Goshtasbi; Mehdi Abouzari; Tyler M Yasaka; Sina Soltanzadeh-Zarandi; Brooke Sarna; Harrison W Lin; Hamid R Djalilian
Journal:  Otol Neurotol       Date:  2021-04-01       Impact factor: 2.619

Review 6.  Shared decision-making in neurosurgery: a scoping review.

Authors:  Alba Corell; Annie Guo; Tomás Gómez Vecchio; Anneli Ozanne; Asgeir S Jakola
Journal:  Acta Neurochir (Wien)       Date:  2021-05-03       Impact factor: 2.216

7.  Patient-reported factors that influence the vestibular schwannoma treatment decision: a qualitative study.

Authors:  O M Neve; G Soulier; M Hendriksma; A G L van der Mey; A van Linge; P P G van Benthem; E F Hensen; A M Stiggelbout
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-07       Impact factor: 2.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.